BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

0.4720 +0.0090 (+1.94%) At close: 05:57PM EEST

BBS-Bioactive Bone Substitutes Oyj

Kiviharjunlenkki 6
Oulu 90220
Finland
358 4070 80307
https://www.bbs-artebone.fi

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 20

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Juliusz Rakowskias	Chief Executive Officer	N/A	N/A	N/A
Mr. Paul C. Watkins	Chief Commercial Officer & Member of Advisory Board	N/A	N/A	N/A
Mikko Viitanen	Head of Quality control laboratory	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.

Corporate governance

BBS-Bioactive Bone Substitutes Oyj’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.